ALX Oncology Holdings Inc.ALXONASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank43
3Y CAGR+10.3%
5Y CAGR-21.8%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+10.3%/yr
vs -60.6%/yr prior
5Y CAGR
-21.8%/yr
Recent acceleration
Acceleration
+70.8pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.33 | +204.3% |
| 2024 | 0.77 | -77.3% |
| 2023 | 3.37 | +93.8% |
| 2022 | 1.74 | -27.0% |
| 2021 | 2.39 | -70.1% |
| 2020 | 7.99 | +100.3% |
| 2019 | -2386.02 | -3417.0% |
| 2018 | 71.93 | - |